Skip to content

Research paper

Carnitine supplementation of parenterally fed neonates.

The Cochrane database of systematic reviews
Q1
Oct 2000
Citations: 63
Influential: 2
Systematic Reviews / Meta-Analyses
90

Study answer

What this study found

Carnitine supplementation did not show convincing benefit for weight gain, lipid tolerance, or ketogenesis in neonates receiving parenteral nutrition. Weight gain results were inconsistent across small trials, with examples including MD 5.60 [-0.12, 11.32] in Bonner 1995b, MD -5.53 [-34.91, 23.85] in Coran 1985, and pooled neutral findings for later outcomes such as MD 0.80 [-3.35, 4.95] at 2 to 4 weeks in Shortland 1998. Secondary outcomes were also largely null: free fatty acids pooled at -0.16 [-0.37, 0.05], triglycerides at -0.69 [-1.84, 0.45], and maximum lipid tolerated at 0.09 [-0.20,…

Study & population
This was a systematic review of randomized trials in newborns requiring parenteral nutrition, including premature infants, very low birth weight infants, and some term post-surgical neonates.
Intervention
Carnitine supplementation was given as the active intervention in 8 randomized trials of parenterally fed neonates, with routes and regimens varying by study.
Key limitation
The evidence base was small, short term, and methodologically diverse, with varied doses, routes, and outcome timing across studies.
View sourceOpen PDF

Original abstract

No abstract is available for this paper.